Comparing Human B Cell Activation by TLR7 and TLR9 Agonists
Author Information
Author(s): Hanten John A, Vasilakos John P, Riter Christie L, Neys Lori, Lipson Kenneth E, Alkan Sefik S, Birmachu Woubalem
Primary Institution: 3M Pharmaceuticals
Hypothesis
The study aims to compare the effects of TLR7 and TLR9 stimulation on human B cell function.
Conclusion
TLR7 and TLR9 agonists induce similar gene and protein expression in purified human B cells.
Supporting Evidence
- Both TLR7 and TLR9 agonists induced similar gene expression profiles in B cells.
- TLR7 and TLR9 stimulation resulted in the production of IgM and IgG.
- CD19+ B cells were purified to ≥99% before stimulation.
Takeaway
This study looks at how two different signals can make B cells work similarly, helping them to fight infections.
Methodology
Purified human CD19+ B cells were stimulated with TLR7-selective, TLR7/8, or TLR9-selective agonists, and gene expression and protein production were evaluated.
Limitations
The study did not separate naïve B cells from memory B cells, which may affect the interpretation of results.
Participant Demographics
The study involved healthy volunteers from whom peripheral blood mononuclear cells were obtained.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website